09/10/2024
5:30 PM | Carlyle Group Inc. (Filed by)
Carlyle Group Inc. (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13D/A | |
09/05/2024
5:37 PM | Soleno Therapeutics (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
| Form SC 13G | |
08/30/2024
5:33 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2024
5:34 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2024
5:35 PM | Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2024
5:36 PM | Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
6:36 PM | Soleno Therapeutics (Issuer)
Vivo Opportunity Fund Holdings, L.P. (Reporting)
Vivo Opportunity, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
08/23/2024
6:14 PM | Soleno Therapeutics (Issuer)
Urbanski Raymond W. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/23/2024
6:16 PM | Soleno Therapeutics (Issuer)
Urbanski Raymond W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
5:16 PM | Bir Dawn Carter (Reporting)
Soleno Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/16/2024
5:18 PM | Bir Dawn Carter (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
5:55 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
5:56 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
5:56 PM | Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
5:57 PM | Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
4:18 PM | Soleno Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2024
3:54 PM | Soleno Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/07/2024
3:00 PM | Soleno Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/19/2024
4:02 PM | Soleno Therapeutics (Filer)
| Form 424B5 | |
07/19/2024
4:04 PM | Soleno Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2024
8:00 AM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
8:01 AM | Soleno Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2024
8:01 AM | Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
8:02 AM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
8:02 AM | Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
8:03 AM | Huang Michael F. (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
8:04 AM | Manning Meredith (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
4:56 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
4:58 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
4:58 PM | Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
5:00 PM | Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
4:13 PM | Melincoff Gwen A (Reporting)
Soleno Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/20/2024
3:17 PM | Soleno Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2024
7:49 PM | MARIO ERNEST (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
7:50 PM | Pauls Matthew (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
7:51 PM | Sinclair Andrew (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
7:52 PM | Soleno Therapeutics (Issuer)
Volck Birgitte (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
7:46 PM | Harris William G (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
3:29 PM | Soleno Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/23/2024
6:11 PM | MARIO ERNEST (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
4:28 PM | Soleno Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Invest before this deal closes on 9/18 (Ad) This company can create aviation fuels from waste, they qualify to help airlines meet net-zero carbon pledges as demand ramps up. The market for this type of fuel is projected to grow 1,500% by 2030.
Invest before this investment round closes on 9/18. Learn more about how you can become a shareholder before their planned Nasdaq listing |
05/01/2024
12:07 PM | Soleno Therapeutics (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
| Form SC 13D/A | |
05/01/2024
12:10 PM | Soleno Therapeutics (Issuer)
Vivo Opportunity Fund Holdings, L.P. (Reporting)
Vivo Opportunity, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
4:53 PM | Huang Michael F. (Reporting)
Soleno Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/30/2024
4:54 PM | Manning Meredith (Reporting)
Soleno Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/22/2024
4:06 PM | Soleno Therapeutics (Filer)
| Form ARS | |
04/22/2024
3:31 PM | Soleno Therapeutics (Filer)
| Form DEF 14A | |
04/22/2024
3:15 PM | Soleno Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/03/2024
8:36 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
8:37 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
8:39 PM | Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
8:40 PM | Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
5:06 AM | Soleno Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
4:35 PM | JANUS HENDERSON GROUP PLC (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13G/A | |
02/07/2024
7:01 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13G/A | |
01/30/2024
3:57 PM | Soleno Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/29/2024
4:42 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
4:44 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
4:47 PM | Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2024
3:31 PM | MARIO ERNEST (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
4:34 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
4:35 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
4:36 PM | Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
4:37 PM | Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
3:16 PM | Soleno Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/15/2023
5:00 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2023
6:57 PM | Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2023
4:09 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/13/2023
8:32 PM | Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
8:32 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
8:34 PM | Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
8:34 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
3:46 PM | Soleno Therapeutics (Subject)
Yen Kristen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/13/2023
3:53 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023
5:17 PM | Soleno Therapeutics (Subject)
Yen Kristen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2023
6:05 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2023
6:21 PM | Mackaness James H (Reporting)
Soleno Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/04/2023
7:41 PM | MARIO ERNEST (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2023
7:02 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2023
7:03 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2023
7:04 PM | Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2023
7:06 PM | Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
8:50 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
8:51 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
8:52 PM | Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
8:52 PM | Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2023
11:15 PM | Soleno Therapeutics (Filer)
| Form EFFECT | |
10/23/2023
3:20 PM | PERCEPTIVE ADVISORS LLC (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13D/A | |
10/20/2023
3:32 PM | Soleno Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
10/16/2023
3:30 PM | Carlyle Group Inc. (Filed by)
Carlyle Group Inc. (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13D/A | |
10/12/2023
3:30 PM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13G | |
Invest before this deal closes on 9/18 (Ad) This company can create aviation fuels from waste, they qualify to help airlines meet net-zero carbon pledges as demand ramps up. The market for this type of fuel is projected to grow 1,500% by 2030.
Invest before this investment round closes on 9/18. Learn more about how you can become a shareholder before their planned Nasdaq listing |
10/12/2023
3:05 PM | COMMODORE CAPITAL LP (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13G | |
10/11/2023
3:30 PM | Soleno Therapeutics (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
| Form SC 13D/A | |
10/10/2023
3:30 PM | Fairmount Funds Management LLC (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13G | |
10/06/2023
10:45 AM | JANUS HENDERSON GROUP PLC (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13G | |
10/05/2023
4:09 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13G | |
10/04/2023
3:30 PM | Soleno Therapeutics (Issuer)
Vivo Opportunity Fund Holdings, L.P. (Reporting)
Vivo Opportunity, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2023
9:36 AM | Soleno Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
10/02/2023
6:54 PM | Abingworth Bioventures VII LP (Reporting)
Abingworth LLP (Reporting)
Carlyle Genesis UK LLC (Reporting)
Carlyle Group Inc. (Reporting)
Carlyle Group Inc. (Reporting)
Carlyle Holdings I GP Inc. (Reporting)
Carlyle Holdings I GP Sub L.L.C. (Reporting)
Carlyle Holdings I L.P. (Reporting)
Carlyle Investment Management LLC (Reporting)
CG Subsidiary Holdings L.L.C. (Reporting)
Soleno Therapeutics (Issuer)
TC Group, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/29/2023
3:51 PM | Soleno Therapeutics (Filer)
| Form 424B5 | |
